Nationwide recall hits blood pressure drug, FDA sets class II risk level

A blood pressure medication has been recalled nationwide, with the Food and Drug Administration (FDA) assigning it a Class II risk level, The Hill reports. The bottles of 25 mg chlorthalidone tablets being recalled carry batch number RISA24002 and an expiration date of March 2027.

The FDA defines Class II as a situation in which a product may cause “temporary or medically reversible adverse health consequences.” The risk level is not as serious as that of a Class I recall. The chlorthalidone recall follows Inventia Healthcare’s June recall of 11,460 bottles of blood pressure medication that also failed to properly dissolve.

Almost half of adult Americans have high blood pressure, according to the Centers for Disease Control and Prevention (CDC). Defined as a blood pressure reading of 130 mm Hg/80 mm Hg or higher, elevated blood pressure can put people at risk of heart disease or stroke, the leading causes of death in the United States, according to the CDC.